معرفی
Dr. Masood Ali serves as a Research Officer and Casual Academic within the School of Pharmacy and Pharmaceutical Sciences at the University of Queensland's Faculty of Health, Medicine and Behavioural Sciences. His research focuses on innovative drug delivery systems with particular expertise in microneedle technology, 3D printing applications for pharmaceuticals, and transdermal delivery mechanisms.
His educational background includes a Doctor of Philosophy in Medical and Pharmaceutical Biotechnology and dual Masters (Research) degrees in Biomaterials, all completed at the University of Queensland. His academic journey demonstrates a strong commitment to advancing pharmaceutical delivery technologies through biomaterials science.
Dr. Ali's research interests center around microneedle-based drug delivery systems, with significant contributions to 3D printed microneedles for transdermal applications, NAD+ delivery, and personalized medicine approaches. His work spans nanomedicine, biofabrication, and skin biomechanics, with applications in dermatological conditions, bone regeneration, and pulmonary drug delivery. Recent publications demonstrate his leadership in characterizing topographical features of microneedle surfaces and developing novel formulations for conditions like psoriasis and vitiligo.
Analysis of his 15 most recent publications reveals a clear research trajectory focused on overcoming biological barriers through advanced delivery systems. His work shows increasing sophistication in 3D printing applications for pharmaceuticals, with recent 2025 publications exploring precision engineering of nanofiber spraying and respiratory tract environments for nanomedicine delivery. The research demonstrates strong interdisciplinary collaboration across pharmaceutical sciences, biomedical engineering, and dermatology.
Dr. Ali is actively involved in research supervision and is currently available for student guidance. His work with the Safe and Effective Medication Collaborative and involvement in projects like OPTMED-D indicate engagement with translational research initiatives aimed at improving medication management in clinical settings.
His laboratory work appears centered around pharmaceutical delivery technology development, particularly microneedle systems and 3D printed medical devices. The research involves characterization of surface topography, formulation development, and evaluation of drug delivery efficacy across various biological barriers including skin and respiratory tissues.
